article thumbnail

New Coronascape tool will help unlock big-data insights for COVID-19

Scienmag

Coronascape will enable scientists to […].

article thumbnail

Big data and cell therapy development: the pharmaphorum podcast

pharmaphorum

The UK biotechnology company is aiming to transform the development of cell therapies using a systematic direct cell conversion & maintenance platform powered by big-data. The post Big data and cell therapy development: the pharmaphorum podcast appeared first on.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Researchers identify RNA editing events that impact gene expression and phenotype

Scienmag

CHOP researchers find small changes in RNA due to RNA editing could have a large impact on gene expression and phenotype Philadelphia, March 9, 2021–Combining computational mining of big data with experimental testing in the lab, researchers at Children’s Hospital of Philadelphia (CHOP) have identified RNA editing events that influence (..)

article thumbnail

Data dive finds cheap diuretic could be Alzheimer’s drug

pharmaphorum

The research has focused on Alzheimer’s associated with an apolipoprotein E4 (APOE4) gene variant known to be a major risk factor for late-onset forms of the disease. All told, five drugs emerged with a gene expression signature that the researchers believed might help neutralise the disease, but the strongest candidate was bumetanide.

article thumbnail

The Importance of CDMO Flexibility: Adapting to the Ever-Changing Pharmaceutical Landscape

Drug Patent Watch

Embracing Digital Transformation The role of Big Data and Artificial Intelligence in healthcare is growing exponentially. Digitalization, including the use of Big Data and AI, allows CDMOs to optimize processes, predict challenges, and make rapid decisions, all of which contribute to greater operational flexibility.

article thumbnail

Integrated evidence generation 2.0: A strategy for every stakeholder

pharmaphorum

These groundbreaking discoveries ushered in a new age of precision and personalized medicine, leading to innovations in novel targeted proteins, cell and gene therapies, and medical devices, which are often accompanied by bespoke diagnostic and testing criteria.

article thumbnail

Technology Trends and Collaborations are Ushering in a New Era of ‘Pharmaceutical Intelligence’

ACRP blog

Through these collaborations, advanced technologies tied to AI and big data are being employed to develop personalized and targeted medicines, ultimately leading to more effective treatments for diseases like cancer and immune deficiencies,” Lyons notes.